A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season
NCT00982163 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34
Last updated 2009-09-23
Summary
The study was designed to evaluate the pattern of seasonal allergic signs and symptoms consistent with ongoing ocular allergic inflammation during ragweed season. It was hypothesized that a pattern of ongoing ocular allergic inflammation existed in certain subjects.
Conditions
- Allergic Conjunctivitis
Sponsors & Collaborators
-
ORA, Inc.
lead INDUSTRY
Principal Investigators
-
H. Jerome Crampton, M.D. · ORA, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2008-09-30
- Completion
- 2009-09-30
Countries
- United States
Study Locations
More Related Trials
-
Grass Observational Study
NCT02075138 ·Status: COMPLETED
-
ToleroMune Ragweed Follow up Study
NCT01448603 ·Status: COMPLETED
-
Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With Rhinoconjunctivitis
NCT00878774 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)
NCT00978029 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen
NCT01936818 ·Status: COMPLETED
-
Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234)
NCT00770315 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber
NCT03496103 ·Status: COMPLETED ·Phase: PHASE1
-
House Dust Mite Observational Study
NCT01949428 ·Status: COMPLETED
-
Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma
NCT02061670 ·Status: COMPLETED ·Phase: PHASE2
-
Ragweed-SPIRE Follow-On Study
NCT02396680 ·Status: COMPLETED
-
ToleroMune Ragweed Exposure Chamber Study
NCT01198613 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms
NCT00891436 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies
NCT00599872 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms
NCT01007253 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy
NCT00293904 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Eosinophil Markers and Development of Disease in Allergic Rhinitis
NCT01192386 ·Status: COMPLETED
-
Is There a Comorbidity Between Migraine and Allergic Rhinitis?
NCT01845051 ·Status: COMPLETED
-
A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)
NCT01385371 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy
NCT00652223 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Specific Immunotherapy With CLUSTOID Grass Pollen
NCT01012531 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen
NCT00791973 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis
NCT00812799 ·Status: UNKNOWN ·Phase: PHASE3
-
Determination of Grass Pollen Allergen Concentration Inducing Rhinoconjunctivitis Symptoms in Subjects Allergic to Grass Pollen in ALYATEC Allergen Exposure Chamber
NCT06104293 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis
NCT00309036 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber
NCT02061709 ·Status: COMPLETED ·Phase: PHASE2